Acasti Pharma Inc. (CVE:ACST – Get Free Report) shot up 1.8% during mid-day trading on Tuesday . The company traded as high as C$0.58 and last traded at C$0.58. 2,450 shares were traded during trading, a decline of 63% from the average session volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Price Performance
The firm’s fifty day simple moving average is C$0.58 and its 200 day simple moving average is C$0.58. The company has a market capitalization of C$18.19 million, a PE ratio of -1.21 and a beta of 1.22.
About Acasti Pharma
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Featured Stories
- Five stocks we like better than Acasti Pharma
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
